You are here: Home » Reuters » News
Business Standard

Thermo Fisher to buy Patheon for $5.2 bln to expand biopharma services


By Bill Berkrot and Natalie Grover(Reuters) - Thermo Fisher Scientific Inc said on Monday it would buy Patheon NV, a Dutch manufacturer of drugs for clinical trials, for $5.2 billion as it seeks to complement its offerings in production and services for the biopharma industry.The offer price of $35 per share represents a premium of about 35 percent to Patheon's Friday close. Thermo will also assume $2 billion in net debt, putting the cost of the deal at about $7.2 billion for Patheon, which generated $1.9 billion in revenue last year.Thermo Fisher, the world's largest maker of scientific ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Tue, May 16 2017. 09:32 IST